Julia Weisinger

5PUBLICATIONS
39CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Jul 29, 2025
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.

Júlia Weisinger, Raïda Bouzid, Jehane Fadlallah

|Apr 24, 2025
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intolerance.

Julia Weisinger, Jehane Fadlallah, Bérangère Joly

|Dec 13, 2024
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Julia Weisinger, Raïda Bouzid, Jehane Fadlallah

|Sep 04, 2024
Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura.

Julia Weisinger, Raïda Bouzid, Dana Ranta

Pageof 1

Frequent Collaborators

2 joint publications

Zora Marjanovic

2 joint publications

Paul Coppo

1 joint publications

Bérangère S Joly

1 joint publications

Wei-Yu Lin